University of Exeter
Browse

The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers

Download (278.56 kB)
journal contribution
posted on 2025-07-31, 23:37 authored by G Lyratzopoulos, CL Saunders, GA Abel, S McPhail, RD Neal, J Wardle, GP Rubin
BACKGROUND: Appreciating variation in the length of pre- or post-presentation diagnostic intervals can help prioritise early diagnosis interventions with either a community or a primary care focus.METHODS: We analysed data from the first English National Audit of Cancer Diagnosis in Primary Care on 10 953 patients with any of 28 cancers. We calculated summary statistics for the length of the patient and the primary care interval and their ratio, by cancer site.RESULTS: Interval lengths varied greatly by cancer. Laryngeal and oropharyngeal cancers had the longest median patient intervals, whereas renal and bladder cancer had the shortest (34.5 and 30 compared with 3 and 2 days, respectively). Multiple myeloma and gallbladder cancer had the longest median primary care intervals, and melanoma and breast cancer had the shortest (20.5 and 20 compared with 0 and 0 days, respectively). Mean patient intervals were longer than primary care intervals for most (18 of 28) cancers, and notably so (two- to five-fold greater) for 10 cancers (breast, melanoma, testicular, vulval, cervical, endometrial, oropharyngeal, laryngeal, ovarian and thyroid).CONCLUSIONS: The findings support the continuing development and evaluation of public health interventions aimed at shortening patient intervals, particularly for cancers with long patient interval and/or high patient interval over primary care interval ratio.

Funding

A18180

Betsi Cadwaladr University Health Board

Cancer Research UK

National Institute for Health Research (NIHR)

PDF-2011-04-047

Public Health Wales

History

Related Materials

Rights

© 2015 Cancer Research UK. This work isl icensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Notes

This is the final version. Available from the publisher via the DOI in this record.

Journal

British Journal of Cancer

Publisher

Springer Nature / Cancer Research UK

Version

  • Version of Record

Language

en

FCD date

2019-02-08T10:49:41Z

FOA date

2019-02-08T10:55:12Z

Citation

Vol. 112, pp. S35 - S40

Department

  • Archive

Usage metrics

    University of Exeter

    Categories

    No categories selected

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC